Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Barbituric acid derivatives, their preparation and use thereof as leukocyte transmigration inhibitors and for treating inflammatory diseases, autoimmune diseases and cancer

Barbituric acid derivatives, their preparation and use thereof as leukocyte transmigration inhibitors and for treating inflammatory diseases, autoimmune diseases and cancer

US Patent 11492333 · Granted Nov 8, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Barbituric acid derivatives, their preparation and use thereof as leukocyte tran2025
Barbituric acid derivatives, their preparation and use thereof as leukocyte tran2025
Barbituric acid derivatives, their preparation and use thereof as leukocyte tran2025
Barbituric acid derivatives, their preparation and use thereof as leukocyte tran2025
Barbituric acid derivatives, their preparation and use thereof as leukocyte tran2025
Barbituric acid derivatives, their preparation and use thereof as leukocyte tran2025
Barbituric acid derivatives, their preparation and use thereof as leukocyte tran2025
Barbituric acid derivatives, their preparation and use thereof as leukocyte tran2025
Barbituric acid derivatives, their preparation and use thereof as leukocyte tran2025
Barbituric acid derivatives, their preparation and use thereof as leukocyte tran2025
Barbituric acid derivatives, their preparation and use thereof as leukocyte tran2025
Barbituric acid derivatives, their preparation and use thereof as leukocyte tran2025